July 26, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis
📊 The healthcare sector has shown dynamic movement over the recent periods. Various stocks have displayed significant shifts in performance within short time frames, reflecting potential market opportunities and risks. This analysis aims to shed light on the market positioning of major healthcare stocks over weekly, monthly, and quarterly spans to assist in strategic alignment and decision-making for stakeholders.
Healthcare Stocks Performance One Week
✅ Over the one-week period, TMO demonstrated remarkable growth, leading with a 6.87% increase. In contrast, ISRG faced a challenging period, declining by 2.21%. This turbulent week highlights the necessity for quick market response and risk management in volatile environments.
| Stock | Performance (%) | Performance |
|---|---|---|
| TMO | 6.87% | |
| JNJ | 4.06% | |
| MRK | 2.84% | |
| AMGN | 2.65% | |
| ABT | 2.38% | |
| ABBV | 1.92% | |
| LLY | 1.54% | |
| UNH | -1.19% | |
| ISRG | -2.21% |
Healthcare Stocks Performance One Month
💡 TMO remains a strong performer with a considerable 10.75% gain over the month. In contrast, ISRG's performance was substantially negative at -16.37%. Evaluating portfolio positions in growing and shrinking stocks might be crucial for agile investment strategies.
| Stock | Performance (%) | Performance |
|---|---|---|
| TMO | 10.75% | |
| ABT | 9.86% | |
| AMGN | 5.04% | |
| JNJ | 3.65% | |
| ABBV | 2.60% | |
| MRK | 2.20% | |
| LLY | -0.69% | |
| UNH | -1.47% | |
| ISRG | -16.37% |
Healthcare Stocks Performance Three Months
📈 Over the last three months, LLY emerged as a critical leader with an impressive 33.72%. ABBV and TMO also showcased robust performances. Conversely, ISRG faced the steepest decline of -30.69%, indicating potential concerns or opportunities for restructuring.
| Stock | Performance (%) | Performance |
|---|---|---|
| LLY | 33.72% | |
| ABBV | 28.41% | |
| TMO | 20.87% | |
| MRK | 18.42% | |
| UNH | 17.88% | |
| JNJ | 16.33% | |
| ABT | 11.89% | |
| AMGN | 10.81% | |
| ISRG | -30.69% |
Summary
🗣️ In conclusion, the healthcare sector's volatility is evident, with standout performances from LLY, ABBV, and TMO across various time horizons. ISRG's persistent underperformance poses significant caution for investors. Strategic adjustments and continuous monitoring are advised to capitalize on growth potentials while mitigating risks. Investors should consider diversified portfolios to balance high-performing stocks with those lagging, ensuring resilience against sector-specific fluctuations.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years